Viloxazine

Generic name: Pronounced as (vye lox' a zeen )
Brand names
  • Qelbree®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 05/15/2021

Studies have shown that children and teenagers with attention-deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) who take viloxazine are more likely to think about killing themselves than children and teenagers with ADHD who do not take viloxazine.

While your child is taking viloxazine, you should watch his or her behavior very carefully, especially at the beginning of treatment and any time his or her dose is increased or decreased. Your child may develop serious symptoms very suddenly, so it is important to pay attention to his or her behavior every day. Ask other people who spend a lot of time with your child, such as brothers, sisters, and teachers to tell you if they notice changes in your child's behavior. Call your child's doctor right away if your child experiences any of these symptoms: acting more subdued or withdrawn than usual; feeling helpless, hopeless, or worthless; new or worsening depression; thinking or talking about harming or killing him- or herself or planning or trying to do so; extreme worry; agitation; panic attacks; difficulty falling asleep or staying asleep; irritability; aggressive or violent behavior; acting without thinking; extreme increase in activity or talking; frenzied, abnormal excitement; or any other sudden or unusual changes in behavior.

Your child's doctor will want to see your child often while he or she is taking viloxazine, especially at the beginning of his or her treatment. Your child's doctor may also want to speak with you or your child by telephone from time to time. Be sure that your child keeps all appointments for office visits or telephone conversations with his or her doctor.

Talk to your doctor about the risks of giving viloxazine to your child, of using other treatments for your child's condition, and of not treating your child's condition.

Viloxazine is used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children 6 to 17 years of age with attention deficit hyperactivity disorder (ADHD). Viloxazine is in a class of medications called selective norepinephrine reuptake inhibitors. It works by increasing the levels of norepinephrine, a natural substance in the brain that is needed to control behavior.

Viloxazine comes as a capsule to take by mouth. It is usually taken either once a day with or without food. Take viloxazine at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take viloxazine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the capsules whole; do not split, chew, or crush them.

If the capsules cannot be swallowed whole, open the capsule and sprinkle the contents onto a teaspoonful of applesauce. Swallow all of the mixture right away; do not chew the mixture. Swallow the mixture within two hours of mixing; do not store the mixture for future use.

Your doctor will probably start you on a low dose of viloxazine and increase your dose after at least 7 days.

Viloxazine may help to control the symptoms of ADHD but will not cure the condition. Continue to take viloxazine even if you feel well. Do not stop taking viloxazine without talking to your doctor.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with viloxazine and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) or the manufacturer's website to obtain the Medication Guide.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking viloxazine,

  • tell your doctor and pharmacist if you are allergic to viloxazine, any other medications, or any of the ingredients in viloxazine capsules. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor if you are taking monoamine oxidase (MAO) inhibitors, including isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), safinamide (Xadago), selegiline (Eldepryl, Emsam, Zelapar), and tranylcypromine (Parnate), or if you have stopped taking them within the past 2 weeks. Also, tell your doctor if you are taking alosetron (Lotronex), duloxetine (Cymbalta), ramelteon (Rozerem), tasimelteon (Hetlioz), tizanidine (Zanaflex), or theophylline. Your doctor will probably tell you not to take viloxazine with any of these medications.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: atomoxetine (Strattera), avanafil (Stendra), buspirone, clozapine (Clozaril, Versacloz), conivaptan (Vaprisol), darifenacin (Enablex), darunavir (Prezista), desipramine (Norpramin), dextromethorphan (found in many cough medications; in Nuedexta), everolimus (Afinitor), ibrutinib (Imbruvica), lomitapide (Juxtapid), lovastatin (Altoprev), lurasidone (Latuda), metoprolol, midazolam, naloxegol (Movantik), nebivolol (Bystolic), nisoldipine (Sular), nortriptyline (Pamelor), perphenazine, pirfenidone (Esbriet), risperidone (Perseris, Risperdal), saquinavir (Invirase), simvastatin (Flolipid, in Vytorin), sirolimus (Rapamune), tacrolimus (Prograf), tipranavir (Aptivus), tolterodine (Detrol), triazolam (Halcion), vardenafil (Levitra), and venlafaxine (Pristiq). Many other medications may also interact with viloxazine, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you or anyone in your family has or has ever had depression, bipolar disorder (manic depressive disorder; a condition that causes episodes of depression, episodes of frenzied, abnormal excitement and other abnormal moods), or has ever thought about or attempted suicide. Also tell your doctor if you have or have ever had high blood pressure, or heart, liver or kidney disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking viloxazine, call your doctor.

  • you should know that viloxazine may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

  • you should know that viloxazine should be used as part of a total treatment program for ADHD, which may include counseling and special education. Make sure to follow all of your doctor's and/or therapist's instructions.

  • you should know that your blood pressure may increase during your treatment with viloxazine. Your doctor will monitor your blood pressure during your treatment.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Viloxazine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • loss of appetite

    • tiredness

    • nausea

    • vomiting

    • headache

  • Viloxazine may affect children's weight gain. Your child's doctor will probably monitor your child carefully during his or her treatment with viloxazine. Talk to your child's doctor about the risks of giving this medication to your child.

  • Viloxazine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • drowsiness

  • loss of consciousness

  • fast or irregular heartbeat

  • muscle weakness

Keep all appointments with your doctor and the laboratory. Your doctor will check your blood pressure and heart rate and order certain lab tests to check your body's response to viloxazine.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Leflunomide Leflunomide The metabolism of Leflunomide can be decreased when combined with Viloxazine.
Dolasetron Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Viloxazine.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Viloxazine.
Anagrelide Anagrelide The metabolism of Anagrelide can be decreased when combined with Viloxazine.
Cilostazol Cilostazol Cilostazol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Viloxazine.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Viloxazine.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Fenofibrate Fenofibrate Fenofibrate may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Guanfacine is combined with Viloxazine.
Magnesium Hydroxide Magnesium Hydroxide Magnesium hydroxide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Mycophenolate Mycophenolate Mycophenolic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Viloxazine.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Viloxazine.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Viloxazine.
Potassium Potassium Potassium cation may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ranitidine Ranitidine Ranitidine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Viloxazine.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Rizatriptan is combined with Viloxazine.
Sumatriptan Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Viloxazine.
Tacrolimus Tacrolimus Tacrolimus may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tizanidine Tizanidine The serum concentration of Tizanidine can be increased when it is combined with Viloxazine.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Viloxazine.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Viloxazine.
Levofloxacin Injection Levofloxacin Injection Levofloxacin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Meperidine Injection Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Viloxazine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Viloxazine.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Viloxazine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Viloxazine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Viloxazine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cyclosporine Cyclosporine Cyclosporine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ondansetron Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Viloxazine.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Viloxazine.
Torsemide Torsemide Torasemide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Viloxazine.
Alosetron Alosetron The risk or severity of adverse effects can be increased when Alosetron is combined with Viloxazine.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Viloxazine.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Viloxazine.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Zaleplon Zaleplon Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Viloxazine.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Viloxazine.
Trimipramine Trimipramine The risk or severity of adverse effects can be increased when Trimipramine is combined with Viloxazine.
Glycopyrrolate Glycopyrrolate Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Perindopril Perindopril Perindopril may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Eplerenone Eplerenone Eplerenone may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram Escitalopram The risk or severity of adverse effects can be increased when Escitalopram is combined with Viloxazine.
Zonisamide Zonisamide Zonisamide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Aripiprazole Aripiprazole The risk or severity of adverse effects can be increased when Aripiprazole is combined with Viloxazine.
Atomoxetine Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Viloxazine.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Viloxazine.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Almotriptan Almotriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Viloxazine.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Viloxazine.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Memantine Memantine Memantine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tadalafil Tadalafil Tadalafil may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Frovatriptan Frovatriptan The risk or severity of adverse effects can be increased when Frovatriptan is combined with Viloxazine.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Viloxazine.
Protriptyline Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Viloxazine.
Duloxetine Duloxetine The risk or severity of adverse effects can be increased when Duloxetine is combined with Viloxazine.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Trospium Trospium Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Viloxazine.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Viloxazine.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Viloxazine is combined with Eszopiclone.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Solifenacin Solifenacin Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Valganciclovir Valganciclovir Valganciclovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Adefovir Adefovir Adefovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Viloxazine.
Entecavir Entecavir The metabolism of Entecavir can be decreased when combined with Viloxazine.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Viloxazine.
Ramelteon Ramelteon The risk or severity of adverse effects can be increased when Ramelteon is combined with Viloxazine.
Darifenacin Darifenacin Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Viloxazine.
Pregabalin Pregabalin The therapeutic efficacy of Viloxazine can be increased when used in combination with Pregabalin.
Felbamate Felbamate The risk or severity of adverse effects can be increased when Felbamate is combined with Viloxazine.
Ranolazine Ranolazine Ranolazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Rasagiline Rasagiline The risk or severity of adverse effects can be increased when Rasagiline is combined with Viloxazine.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Viloxazine.
Sitagliptin Sitagliptin Sitagliptin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Varenicline Varenicline Varenicline may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Albuterol Albuterol Salbutamol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Paliperidone Paliperidone The risk or severity of adverse effects can be increased when Paliperidone is combined with Viloxazine.
Bortezomib Bortezomib The metabolism of Bortezomib can be decreased when combined with Viloxazine.
Clofarabine Injection Clofarabine Injection Clofarabine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Viloxazine.
Pemetrexed Injection Pemetrexed Injection Viloxazine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Viloxazine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Sorafenib Sorafenib The metabolism of Viloxazine can be decreased when combined with Sorafenib.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Levocetirizine is combined with Viloxazine.
Pegaptanib Injection Pegaptanib Injection Pegaptanib may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Viloxazine.
Mexiletine Mexiletine The metabolism of Mexiletine can be decreased when combined with Viloxazine.
Azacitidine Injection Azacitidine Injection Azacitidine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Budesonide Budesonide Budesonide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Viloxazine.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Viloxazine.
Doripenem Injection Doripenem Injection Doripenem may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Arsenic trioxide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Viloxazine.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Viloxazine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Viloxazine.
Certolizumab Injection Certolizumab Injection Certolizumab pegol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Viloxazine.
Methylnaltrexone Injection Methylnaltrexone Injection Methylnaltrexone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Viloxazine.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Viloxazine.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Viloxazine.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Milnacipran is combined with Viloxazine.
Plerixafor Injection Plerixafor Injection Plerixafor may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Fesoterodine Fesoterodine Fesoterodine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Viloxazine.
Iloperidone Iloperidone The risk or severity of adverse effects can be increased when Iloperidone is combined with Viloxazine.
Prasugrel Prasugrel Prasugrel may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Lacosamide is combined with Viloxazine.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Viloxazine.
Pralatrexate Injection Pralatrexate Injection Pralatrexate may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Viloxazine.
Saxagliptin Saxagliptin Saxagliptin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Telavancin Injection Telavancin Injection Telavancin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Topotecan Topotecan Topotecan may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Viloxazine.
Asenapine Asenapine The risk or severity of adverse effects can be increased when Asenapine is combined with Viloxazine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Viloxazine.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Viloxazine.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Viloxazine.
Dalfampridine Dalfampridine Dalfampridine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Viloxazine.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Lurasidone is combined with Viloxazine.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Vilazodone Vilazodone The risk or severity of adverse effects can be increased when Vilazodone is combined with Viloxazine.
Ipilimumab Injection Ipilimumab Injection Ipilimumab may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Terbutaline may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Roflumilast Roflumilast Roflumilast may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Rivaroxaban Rivaroxaban Rivaroxaban may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ruxolitinib Ruxolitinib Ruxolitinib may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Clobazam Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Viloxazine.
Deferiprone Deferiprone Deferiprone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Viloxazine.
Cabergoline Cabergoline The risk or severity of adverse effects can be increased when Cabergoline is combined with Viloxazine.
Naloxone Injection Naloxone Injection Naloxone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Viloxazine.
Enzalutamide Enzalutamide Enzalutamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Mirabegron Mirabegron Mirabegron may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Teduglutide Injection Teduglutide Injection Teduglutide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Alogliptin Alogliptin Alogliptin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Pomalidomide Pomalidomide The metabolism of Viloxazine can be decreased when combined with Pomalidomide.
Canagliflozin Canagliflozin Canagliflozin may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Trametinib Trametinib Trametinib may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Levomilnacipran Levomilnacipran The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Viloxazine.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Vortioxetine Vortioxetine The risk or severity of adverse effects can be increased when Vortioxetine is combined with Viloxazine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Sofosbuvir Sofosbuvir Sofosbuvir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast Apremilast may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Droxidopa Droxidopa Droxidopa may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Viloxazine is combined with Eslicarbazepine.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Hydrocodone Hydrocodone Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Suvorexant Suvorexant Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Edoxaban Edoxaban Edoxaban may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Methamphetamine Methamphetamine The risk or severity of adverse effects can be increased when Metamfetamine is combined with Viloxazine.
Tasimelteon Tasimelteon The risk or severity of adverse effects can be increased when Tasimelteon is combined with Viloxazine.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Viloxazine.
Risperidone Injection Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Viloxazine.
Haloperidol Injection Haloperidol Injection The risk or severity of CNS depression can be increased when Haloperidol is combined with Viloxazine.
Amiloride Amiloride Amiloride may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Macitentan may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Flibanserin Flibanserin The risk or severity of adverse effects can be increased when Flibanserin is combined with Viloxazine.
Brexpiprazole Brexpiprazole The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Viloxazine.
Ziprasidone Injection Ziprasidone Injection The risk or severity of adverse effects can be increased when Ziprasidone is combined with Viloxazine.
Cariprazine Cariprazine The risk or severity of adverse effects can be increased when Cariprazine is combined with Viloxazine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Viloxazine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Ixazomib Ixazomib Viloxazine may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Viloxazine may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Brivaracetam Injection Brivaracetam Injection The risk or severity of adverse effects can be increased when Brivaracetam is combined with Viloxazine.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Pimavanserin is combined with Viloxazine.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Viloxazine.
Furosemide Injection Furosemide Injection Furosemide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Viloxazine.
Lixisenatide Injection Lixisenatide Injection Viloxazine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Doxepin.
Deutetrabenazine Deutetrabenazine Viloxazine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Viloxazine may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Safinamide Safinamide The risk or severity of adverse effects can be increased when Safinamide is combined with Viloxazine.
Naldemedine Naldemedine Viloxazine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Viloxazine.
Benznidazole Benznidazole Viloxazine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Viloxazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide Apalutamide Viloxazine may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Baricitinib Baricitinib Viloxazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The therapeutic efficacy of Viloxazine can be increased when used in combination with Lofexidine.
Plazomicin Injection Plazomicin Injection Viloxazine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Viloxazine.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Viloxazine.
Stiripentol Stiripentol The risk or severity of adverse effects can be increased when Stiripentol is combined with Viloxazine.
Prucalopride Prucalopride Prucalopride may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Viloxazine is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of adverse effects can be increased when Viloxazine is combined with Solriamfetol.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Viloxazine.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Viloxazine.
Pitolisant Pitolisant Viloxazine may decrease the excretion rate of Pitolisant which could result in a higher serum level.
Phenytoin Injection Phenytoin Injection The risk or severity of adverse effects can be increased when Phenytoin is combined with Viloxazine.
Fosphenytoin Injection Fosphenytoin Injection The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Viloxazine.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Lumateperone is combined with Viloxazine.
Lasmiditan Lasmiditan The risk or severity of adverse effects can be increased when Viloxazine is combined with Lasmiditan.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Viloxazine.
Lemborexant Lemborexant The risk or severity of adverse effects can be increased when Viloxazine is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of adverse effects can be increased when Fenfluramine is combined with Viloxazine.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Viloxazine.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Trazodone Trazodone The risk or severity of adverse effects can be increased when Trazodone is combined with Viloxazine.
Isotretinoin Isotretinoin Isotretinoin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Phenobarbital Phenobarbital The risk or severity of adverse effects can be increased when Phenobarbital is combined with Viloxazine.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Viloxazine.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Viloxazine.
Primidone Primidone The risk or severity of adverse effects can be increased when Primidone is combined with Viloxazine.
Methsuximide Methsuximide The risk or severity of adverse effects can be increased when Methsuximide is combined with Viloxazine.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Diethylpropion is combined with Viloxazine.
Chlorpromazine Chlorpromazine The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Viloxazine.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Viloxazine.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Viloxazine.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Viloxazine.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Viloxazine.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Viloxazine.
Carmustine Carmustine Carmustine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Amantadine Amantadine Amantadine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Viloxazine.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Viloxazine.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Viloxazine.
Bromocriptine Bromocriptine The risk or severity of adverse effects can be increased when Bromocriptine is combined with Viloxazine.
Tranylcypromine Tranylcypromine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Viloxazine.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Viloxazine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Viloxazine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Viloxazine.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Prochlorperazine Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Viloxazine.
Thioridazine Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Viloxazine.
Trifluoperazine Trifluoperazine The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Viloxazine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Oxycodone Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Viloxazine.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Viloxazine.
Oxybutynin Oxybutynin Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine Benztropine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Maprotiline Maprotiline The risk or severity of adverse effects can be increased when Maprotiline is combined with Viloxazine.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Trihexyphenidyl Trihexyphenidyl Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Viloxazine.
Azathioprine Azathioprine Azathioprine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Fluphenazine Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Viloxazine.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of adverse effects can be increased when Amoxapine is combined with Viloxazine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Carbamazepine Carbamazepine Carbamazepine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Molindone Molindone The risk or severity of adverse effects can be increased when Molindone is combined with Viloxazine.
Methyldopa Methyldopa Methyldopa may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Viloxazine.
Hydralazine Hydralazine Hydralazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Warfarin Warfarin The metabolism of Warfarin can be decreased when combined with Viloxazine.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Clonazepam is combined with Viloxazine.
Promethazine Promethazine Promethazine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Digoxin Digoxin Viloxazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Viloxazine.
Chloroquine Chloroquine Chloroquine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Quinine Quinine The risk or severity of adverse effects can be increased when Quinine is combined with Viloxazine.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Viloxazine.
Triamterene Triamterene Triamterene may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital The risk or severity of adverse effects can be increased when Secobarbital is combined with Viloxazine.
Desipramine Desipramine Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Desipramine.
Amitriptyline Amitriptyline Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Viloxazine.
Probenecid Probenecid Probenecid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Quinidine Quinidine Viloxazine may decrease the excretion rate of Quinidine which could result in a higher serum level.
Procainamide Procainamide Viloxazine may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid Isoniazid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Disopyramide Disopyramide Disopyramide may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Valproic Acid Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Viloxazine.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Viloxazine.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Viloxazine.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Methimazole Methimazole Methimazole may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tolbutamide Tolbutamide Tolbutamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tolazamide Tolazamide Tolazamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Dextromethorphan Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Viloxazine.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Viloxazine is combined with Cyclobenzaprine.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Viloxazine.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Cyproheptadine Cyproheptadine The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Viloxazine.
Clemastine Clemastine The risk or severity of adverse effects can be increased when Clemastine is combined with Viloxazine.
Chlorpheniramine Chlorpheniramine The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Viloxazine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Viloxazine.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Viloxazine.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Dantrolene is combined with Viloxazine.
Chlorzoxazone Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Viloxazine.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Viloxazine.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Viloxazine.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Propranolol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Nortriptyline Nortriptyline Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Nadolol Nadolol Nadolol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Viloxazine.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Viloxazine.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Viloxazine.
Flavoxate Flavoxate Flavoxate may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Viloxazine.
Colchicine Colchicine Colchicine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Dacarbazine Dacarbazine The metabolism of Viloxazine can be decreased when combined with Dacarbazine.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Viloxazine.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Viloxazine is combined with Pyrantel.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Metoprolol Metoprolol Metoprolol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Thiothixene Thiothixene The risk or severity of adverse effects can be increased when Thiothixene is combined with Viloxazine.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Viloxazine.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Viloxazine.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Viloxazine.
Dicyclomine Dicyclomine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Hyoscyamine Hyoscyamine Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Propantheline may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Nifedipine Nifedipine Nifedipine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Timolol Timolol Timolol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Verapamil Verapamil Verapamil may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Pindolol Pindolol The risk or severity of adverse effects can be increased when Pindolol is combined with Viloxazine.
Cisplatin Injection Cisplatin Injection Viloxazine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Bumetanide Bumetanide Bumetanide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Viloxazine.
Glipizide Glipizide Glipizide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Indapamide Indapamide Indapamide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Labetalol Labetalol Labetalol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Auranofin Auranofin Auranofin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Gemfibrozil Gemfibrozil Gemfibrozil may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Guanabenz Guanabenz The metabolism of Guanabenz can be decreased when combined with Viloxazine.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Pimozide Pimozide The metabolism of Viloxazine can be decreased when combined with Pimozide.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Fluoxetine Fluoxetine Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Clozapine Clozapine The risk or severity of adverse effects can be increased when Clozapine is combined with Viloxazine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Estazolam is combined with Viloxazine.
Didanosine Didanosine Didanosine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Etodolac Etodolac Etodolac may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Bisoprolol Bisoprolol Bisoprolol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Zolpidem Zolpidem Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Isradipine Isradipine Isradipine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cisapride Cisapride The risk or severity of adverse effects can be increased when Cisapride is combined with Viloxazine.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Viloxazine.
Venlafaxine Venlafaxine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Viloxazine.
Fluvoxamine Fluvoxamine The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Viloxazine.
Nefazodone Nefazodone The risk or severity of adverse effects can be increased when Nefazodone is combined with Viloxazine.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Viloxazine.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tramadol Tramadol The risk or severity of CNS depression can be increased when Tramadol is combined with Viloxazine.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ifosfamide Injection Ifosfamide Injection Ifosfamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Nicardipine Nicardipine Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Bupropion is combined with Viloxazine.
Ticlopidine Ticlopidine Ticlopidine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Metformin Metformin Metformin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Nisoldipine Nisoldipine Nisoldipine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Riluzole Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Viloxazine.
Acarbose Acarbose Acarbose may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Viloxazine can be decreased when combined with Clomipramine.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Mirtazapine Mirtazapine Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Viloxazine.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Viloxazine.
Pramipexole Pramipexole Viloxazine may increase the sedative activities of Pramipexole.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Viloxazine.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Viloxazine.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Flutamide Flutamide Flutamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Selegiline Selegiline The risk or severity of adverse effects can be increased when Selegiline is combined with Viloxazine.
Sertraline Sertraline The risk or severity of adverse effects can be increased when Sertraline is combined with Viloxazine.
Propafenone Propafenone The metabolism of Propafenone can be decreased when combined with Viloxazine.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Viloxazine is combined with Ropinirole.
Quetiapine Quetiapine The risk or severity of adverse effects can be increased when Quetiapine is combined with Viloxazine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Viloxazine.
Paroxetine Paroxetine The risk or severity of adverse effects can be increased when Paroxetine is combined with Viloxazine.
Tolcapone Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Viloxazine.
Citalopram Citalopram The risk or severity of adverse effects can be increased when Citalopram is combined with Viloxazine.
Capecitabine Capecitabine Capecitabine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Efavirenz Efavirenz The risk or severity of adverse effects can be increased when Efavirenz is combined with Viloxazine.
Abacavir Abacavir Abacavir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tolterodine Tolterodine Tolterodine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Thalidomide Thalidomide Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Nateglinide Nateglinide Nateglinide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Viloxazine.
Rabeprazole Rabeprazole Rabeprazole may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Viloxazine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists